CHEK1 in breast cancer is also a notable regulator of the response to DNA damage, which is over-expressed in triple-negative breast cancer (TNBC) and has therefore been proposed as a potential target for treatment [51]. This evidence concerns the gene CHEK1 and triple-negative breast carcinoma.